Alternative Treatment Paradigm for Natalizumab Trial

NCT01710228 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped sponsor stopped

Conditions

Multiple Sclerosis (MS)

Interventions

DRUG: methylprednisolone

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]